NATIONAL STANDARD METHODS: ASSURING QUALITY IN UK Portugal

Size: px
Start display at page:

Download "NATIONAL STANDARD METHODS: ASSURING QUALITY IN UK Portugal"

Transcription

1 NATIONAL STANDARD METHODS: ASSURING QUALITY IN UK Portugal Valerie Bevan Department for Evaluations and Standards Laboratory Centre for Infections Health Protection Agency October 2008

2

3 Structure of talk Background to: Health Protection Agency (HPA) Centre for Infections (CfI) Department for Evaluations, Standards and Training (DEST) Standardising methods How we develop them Why What they look like How you can access them Department for Evaluations, Standards and Training (DEST)

4 HPA Board Executive Local & Regional Services Regional Microbiology Network Corporate Services Centre for Infections Centre for Emergency Preparedness & Response Centre for Radiation Chemicals & Environmental Hazards

5 Main purpose of HPA Dedicated to protecting people s health

6

7 Centre for Infection Epidemiology / surveillance Reference Microbiology

8 Department for Evaluations, Standards and Training (DEST) Head of Department & Laboratory Director: Valerie Bevan Standards Unit Quality System Unit Evaluations Unit (MiDAS) Quality Control Reagents Unit Education & Training Unit Ruhi Siddiqui Professor Ian Sharp Dr Keith Perry Joe Vincini Dr Satnam Sagoo

9 Quality Assurance Patient Test selection Patient preparation Specimen collection Specimen preservation Specimen Selection QA EQA IQA IQC Specimen reception Unique lab identifier Analysis Analytical validation Laboratory SOPs Clinical validation Accreditation checks compliance Results dispatched Results interpreted Clinical management Reporting and Interpretation [Seth J. Quality Assurance. In: CP Price, DJ Newham (eds) Principles and Practice of Immunoassay. 2nd ed. London. pp ]

10 Title Lorian cycle (? 1982)

11 What do we mean by assuring quality? Working to a good quality system Adequate quality assurance (EQA, IQC, IQA) Having a service culture focussed on the user / clinician and patient Good reporting of all diseases for surveillance, according to local requirements Timeliness of reporting High quality clinical advice and interpretation of results Public health focus Meeting accreditation standards Having good standard operating procedures Quality manual

12 Department for Evaluations, Standards and Training (DEST) Head of Department & Laboratory Director: Valerie Bevan Standards Unit Quality System Unit Evaluations Unit (MiDAS) Quality Control Reagents Unit Education & Training Unit Ruhi Siddiqui Professor Ian Sharp Dr Keith Perry Joe Vincini Dr Satnam Sagoo

13 National Standard Methods (NSMs) Comprehensive collection of > 200 well referenced: clinical microbiology standard operating procedures algorithms (virology and serology) guidance notes

14 ~Over 200 National Standard Methods 84 Clinical bacteriology BSOPs 37 BSOP IDs / BSOP TPs Virology / serology algorithms and SOPs 40 Food, water and environmental 39 Guidance Notes 5 Syndromic algorithms (in development)

15 INVESTIGATION OF FAECES SPECIMENS FOR BACTERIAL PATHOGENS BSOP 30

16 SOPs (NSMs) Index Amendment procedure Scope Introduction Technical information Safety considerations Specimen collection Specimen transport & storage Specimen processing Reporting References

17 Working Group Meetings All day meetings 2-4 times a years for each group Working Groups: Bacteriology Virology Syndromic Algorithms Molecular Technology (being formed) Food, Water and Dairy Multi-professional composition: Chairperson Members of the Standards Unit - Unit Head - Co-ordinator/Secretariat Medical microbiologists Healthcare scientists Stakeholder representatives Editor (does not attend meetings)

18 Stakeholders experts and stakeholders Curator Stakeholders

19 SM Working Group Consult Write Draft Standards Unit 1 st draft Via Web Consult Process 2 nd draft Via Web

20 Access Final versions in Adobe.pdf format Access to drafts and reviews (in MS Word) requires password Over 1300 passwords in 75 countries to access our website for NSMs

21 11 May 2006

22

23

24 National Standard Methods (VSOP) Laboratory testing strategies Minimum acceptable standards Frontline testing Confirmatory strategies - algorithm flowchart format or - working standard operating procedure (SOP) format Some with limited access eg H5N1 influenza

25 Anti HIV screening VSOP 11

26 Standard Operating Procedures (VSOP)

27 Clinical Guidance Notes (QSOP)

28 Syndromic algorithms Hepatitis in Neonates = PCR = Serology = Isolation

29 Acute Infective Hepatitis Syndromic Algorithm

30 Syndromic algorithms Bench level guide Front end Link bacteriology and virology testing Make informed decisions Selection of tests Appropriate samples Appropriate reporting Cross referencing to relevant NSMs

31 Why use National Standard Methods? Assist in Accreditation, Quality, Safety, Staff training Links with regulatory bodies, professional microbiology organisations, public health and epidemiologists Facilitates the movement of staff across laboratories Honest broker when laboratories merge Well referenced, provide advice, existing best practice Improve the quality of epidemiological data Removes the need for labs to produce methods from 1 st principles Wide consultation (>1300 password holders), regular review periods ensure documents are current Enables rapid responses to changes required Accessible to all for FREE via the Internet (and with a password)

32 Feedback received The introductions are very useful especially for the BMS examinations You provide reassurance to laboratories regarding methods employed The methods provide a good basis when applying for funding for infrastructure

33 What we are moving towards Documents to be interactive Documents taking presenting symptom to the diagnosis Facilitating molecular diagnostics Improving links with clinical microbiology Book of introductions Pathopedia (with Royal College of Pathologists)

34 Department for Evaluations, Standards and Training (DEST) Head of Department & Laboratory Director: Valerie Bevan Standards Unit Quality System Unit Evaluations Unit (MiDAS) Quality Control Reagents Unit Education & Training Unit Ruhi Siddiqui Professor Ian Sharp Dr Keith Perry Joe Vincini Dr Satnam Sagoo

35 See websites for published reports

36 Evaluations

37 CE Marking CE Marking does not cover: Comparative data Evaluation and validation Ease of Use Monitoring of internal QCs External QA Use of combinations ie kits/automated platforms

38 Murex HIV Access HIV 1/2 New Abbott HIV1/2 3 rd Gen Plus AxSYM HIV Ag/Ab Combo Murex HIV AgAb Combination Genscreen PLUS HIV AgAb Vironostika HIV Uni-Form II AgAb Murex HIV 1+2 Ortho Ab Capt. ELISA Enzygnost HIV1/2 plus Murex ICE HIV 1+2 Innotest HIV 1/2 Earliest HIV Detection Detect-HIV v.4 Prism HIV Ag/Ab Combo Genscreen ULTRA HIV Ag-Ab VIDAS HIV DUO Earliest anti- HIV Detection Enzygnost HIV Integral Genscreen HIV Version 2 Vitros ECi anti-hiv 1+2 Biotest Anti-HIV Tetra ELISA AxSYM HIV 1/2 go Biotest HIV 1/2 recombinant Vironostika HIV Uni-Form II plus O IMx HIV1/2 III plus Clonesystems Detect HIV v1 This figure is based on data generated by testing 21 seroconversion panels in each of the HIV screening tests shown. = Combined Ag/Ab assay = immunometric assay = Class specific antibody capture assay = antiglobulin assay.

39 Department for Evaluations, Standards and Training (DEST) Head of Department & Laboratory Director: Valerie Bevan Standards Unit Quality System Unit Evaluations Unit (MiDAS ) Quality Control Reagents Unit Education & Training Unit Ruhi Siddiqui Professor Ian Sharp Dr Keith Perry Joe Vincini Dr Satnam Sagoo

40

41 Quality Control Reagents we provide Current list of reagents for serology Annex II List A HIV HTLV Hepatitis B Hepatitis C HIV p24 antigen Annex II List B Toxoplasma CMV Rubella Non-Annex II Hepatitis A HSV Syphilis Malaria Influenza H5

42 Countries where we sell Quality Control Reagents UK Canada China Denmark Eire Estonia France Germany Italy Netherlands Norway Singapore Sweden South Korea Taiwan Turkey USA Ukraine

43 Summary NSMs are based on a consensus supported by literature Wide consultation Led by professionals and consult with recognised experts Hosted by HPA Supported by NHS and other stakeholders Progressive and responsive Current and regularly reviewed Free! Quality if multifactorial!

44 Evaluations and Standards Laboratory

45 Acknowledgements Virology working group Ken Mutton (chair and editor for Clinical Virology Network) Medical Editor Dr Mark Farrington Members of Working Groups Department for Evaluations, Standards and Training All in DEST, especially: Keith Perry Ruhi Siddiqui, Jyotsna Vohra, Clare Harris, Russell Croker, Janet Norcup Ian Sharp Joe Vincini Health Protection Agency [2008]

46

47

Anti-Infective Clinical Trials

Anti-Infective Clinical Trials Anti-Infective Clinical Trials The extensive clinical training and experience of our infectious disease staff places us in a unique position to fully appreciate the requirements of our clients conducting

More information

Infectious Disease Testing. ULTRA Product Line. Safety is not a Matter of Chance

Infectious Disease Testing. ULTRA Product Line. Safety is not a Matter of Chance Infectious Disease Testing ULTRA Product Line Safety is not a Matter of Chance ULTRA Product Line The best answer for HBV, HCV and HIV screening: a global automated solution for safe results. Monolisa

More information

UK Standards for Microbiology Investigations

UK Standards for Microbiology Investigations UK Standards for Microbiology Investigations Blood Borne Virus Testing in Dialysis Patients Issued by the Standards Unit, Microbiology Services, PHE Virology V 10 Issue no: 2 Issue date: 27.04.15 Page:

More information

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2018Apr19

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2018Apr19 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Serology Quality Assessment Program Summary

More information

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2017Apr19

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2017Apr19 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Serology Quality Assessment Program Summary

More information

HIV Serology Quality Assessment Program Revised Summary for Panel HIVSER 2017Oct27

HIV Serology Quality Assessment Program Revised Summary for Panel HIVSER 2017Oct27 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Serology Quality Assessment Program Revised

More information

Schedule of Accreditation

Schedule of Accreditation Schedule of Accreditation Organisation Name National Virus Reference Laboratory INAB Reg No 326MT Contact Name Eimear Malone Address University College Dublin, Belfield, Dublin Contact Phone No 01-7161319

More information

HIV-1 AccuVert TM Seroconversion Panel

HIV-1 AccuVert TM Seroconversion Panel PACKAGE INSERT PRB954 (0600-0238) INTENDED USE The is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot test methods. Characterized

More information

The use of QCMD proficiency testing panels in clinical virology.

The use of QCMD proficiency testing panels in clinical virology. The use of QCMD proficiency testing panels in clinical virology. Prof.dr. Bert Niesters Department of Medical Microbiology Division of Clinical Virology UMC Groningen Disease Disease Management Viral Load

More information

United Kingdom National External Quality Assessment Service for Microbiology [Established 1971]

United Kingdom National External Quality Assessment Service for Microbiology [Established 1971] United Kingdom National External Quality Assessment Service for Microbiology [Established 97] UK NEQAS covers Andrology Chemistry Genetics Haematology Histopathology Immunology Leucocyte Immunophenotyping

More information

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities OIE Reference Laboratory Reports Activities Activities in 2016 This report has been submitted : 2017-01-31 14:46:00 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Newcastle

More information

BioPlex 2200 Infectious Disease Panels

BioPlex 2200 Infectious Disease Panels BioPlex 2200 System BioPlex 2200 Infectious Disease Panels An Expanding Multiplexed Assay Menu Lyme HIV Ag-Ab MMV IgM Syphilis Total & RPR MMRV EBV HSV-1 & HSV-2 EBV IgM ToRC IgM ToRC Leading the way with

More information

T pallidum. Table of contents

T pallidum. Table of contents An assessment of Point of Care Tests for Hepatitis B, Hepatitis C, HIV and Syphilis for use in an Operational Environment to Provide Emergency Transfusion Support Microbiological Diagnostics Assessment

More information

AccuVert HIV-1 Seroconversion Panel PRB955 ( ) / Batch #

AccuVert HIV-1 Seroconversion Panel PRB955 ( ) / Batch # Signal to cutoff (s/co) Copies per ml (c/ml) OVERVIEW AccuVert is a 5-member validation panel of undiluted, naturally occurring plasma samples (1 vial per member, 1.0 ml per vial). Panel members represent

More information

HIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2018Oct26

HIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2018Oct26 1 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Viral Load Quality Assessment Program Summary

More information

Global Fund Quality Assurance Policy for Diagnostics products : collaboration with WHO DLT

Global Fund Quality Assurance Policy for Diagnostics products : collaboration with WHO DLT Global Fund Quality Assurance Policy for Diagnostics products : collaboration with WHO DLT Pharmaceutical Management Unit Quality Assurance and Data Management Team QA for health products financed by Global

More information

Bio-Rad Laboratories. Cardiac Assessment Controls. Value Assigned for Clinical Laboratory and Point of Care Test Systems

Bio-Rad Laboratories. Cardiac Assessment Controls. Value Assigned for Clinical Laboratory and Point of Care Test Systems Bio-Rad Laboratories Cardiac Assessment Controls Cardiac Assessment Controls Value Assigned for Clinical Laboratory and Point of Care Test Systems Solving the Challenges of Troponin I Testing for the Central

More information

HIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2017Oct27

HIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2017Oct27 1 The National Laboratory for HIV Reference Services is Accredited to ISO 15189 and ISO 17043 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology

More information

HTLV Serology Quality Assessment Program Summary for Panel HTLS Oct22

HTLV Serology Quality Assessment Program Summary for Panel HTLS Oct22 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory HTLV Serology Quality Assessment Program Summary for Panel HTLS425 2015Oct22

More information

HIV Serology Quality Assessment Program Summary for Panel HIVS Oct22

HIV Serology Quality Assessment Program Summary for Panel HIVS Oct22 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Serology Quality Assessment Program Summary

More information

HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 2017Apr19

HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 2017Apr19 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 2017Apr19

More information

Diagnostics: Bench to Bedside Pathway

Diagnostics: Bench to Bedside Pathway Diagnostics: Bench to Bedside Pathway Rosanna W Peeling Professor and Chair, Diagnostic Research Director, International Diagnostics Centre London School of Hygiene & Tropical Medicine www.idx-dx.org The

More information

CARIBBEAN REGION EXTERNAL QUALITY ASSESSMENT SCHEME. Evaluation Booklet. Performance Evaluation Panel OPS0106 C. Coordination:

CARIBBEAN REGION EXTERNAL QUALITY ASSESSMENT SCHEME. Evaluation Booklet. Performance Evaluation Panel OPS0106 C. Coordination: EXTERNAL QUALITY ASSESSMENT SCHEME Evaluation Booklet CARIBBEAN REGION Performance Evaluation Panel OPS0106 C Coordination: Fundação Pró-Sangue Hemocentro de São Paulo Pan American Health Organization

More information

HIV-1 Seroconversion Panel

HIV-1 Seroconversion Panel OVERVIEW This Data Sheet contains test results specific for HIV-1. s are undiluted aliquots from plasma units collected from a single donor. No preservatives were added. CAUTION: Potentially infectious

More information

UNDER REVIEW. UK Standards for Microbiology Investigations. Epstein-Barr Virus Serology

UNDER REVIEW. UK Standards for Microbiology Investigations. Epstein-Barr Virus Serology UK Standards for Microbiology Investigations Issued by the Standards Unit, Microbiology Services, PHE Virology V 26 Issue no: 4.1 Issue date: 15.04.14 Page: 1 of 12 Crown copyright 2014 Acknowledgments

More information

Cardiac Assessment Controls

Cardiac Assessment Controls Bio-Rad Laboratories CARDIAC ASSESSMENT CONTROLS Cardiac Assessment Controls Value Assigned for Clinical Laboratory and Point of Care Test Systems Solving the Challenges of Troponin I Testing for the Central

More information

HIV Testing and Systems for Managing HIV Implementation in Resource Limited Settings

HIV Testing and Systems for Managing HIV Implementation in Resource Limited Settings HIV Testing and Systems for Managing HIV Implementation in Resource Limited Settings Elizabeth M. Dax with the staff of the National Serology Reference Laboratory, Australia My Background Worked in HIV

More information

FINAL REPORT HBV Serology External Quality Assessment Scheme

FINAL REPORT HBV Serology External Quality Assessment Scheme FINAL REPORT HBV Serology External Quality Assessment Scheme Programme codes: HBVC4310, HBVC435 Panel ID: 2008/Mar/11 HBV Serology EQAS Panel ID 2008/Mar/11 Page 1 of 9 The NRL is a: NATA-accredited proficiency

More information

CAUTION: Refer to the Document Library for the most recent version of this policy. Policy for the use of Cytomegalovirus (CMV) negative blood products

CAUTION: Refer to the Document Library for the most recent version of this policy. Policy for the use of Cytomegalovirus (CMV) negative blood products Directorate Department Year Version Number Central Index Number Endorsing Committee Date Endorsed Approval Committee Date Approved Author Name and Job Title Key Words (for search purposes) Date Published

More information

Weekly Influenza Surveillance Report. Week 11

Weekly Influenza Surveillance Report. Week 11 Weekly Influenza Surveillance Report Week 11 Report produced: 22/03/2001 Influenza activity in Ireland For the week ending the 18/03/01, week 11, influenza activity has increased. Sentinel general practices

More information

Donor Screening in The Region. Vincini GA NRL, Melbourne, Australia

Donor Screening in The Region. Vincini GA NRL, Melbourne, Australia Donor Screening in The Region Vincini GA NRL, Melbourne, Australia NRL Established in 1985 Not-for-profit organisation that exists to support laboratories that perform testing for the diagnosis and management

More information

Il ruolo delle VEQ per la sicurezza trasfusionale

Il ruolo delle VEQ per la sicurezza trasfusionale Il ruolo delle VEQ per la sicurezza trasfusionale The role of EQA for transfusion safety Giulio Pisani CNCF Ist. Sup. Sanità Global Blood Product Safety, Roma 10 aprile 2019 Blood transfusion is an essential

More information

GLP in the European Union Ecolabel detergents, GLP and accreditation

GLP in the European Union Ecolabel detergents, GLP and accreditation GLP in the European Union Ecolabel detergents, GLP and accreditation Maik Schmahl Brussels, 25/03/2010 Chemicals Unit Outline What is GLP? How has it developed? The role of the Member States, the European

More information

CEPHIA Consortium for the Evaluation and Performance of HIV Incidence Assays STANDARD OPERATING PROCEDURE

CEPHIA Consortium for the Evaluation and Performance of HIV Incidence Assays STANDARD OPERATING PROCEDURE CEPHIA Consortium for the Evaluation and Performance of HIV Incidence Assays STANDARD OPERATING PROCEDURE TITLE : SOP for (off board dilution) Less Sensitive Modified VITROS Enzyme Immunoassay CEPHIA DOCUMENT

More information

Multichem Infectious Disease QC

Multichem Infectious Disease QC Infectious Disease QC Contents Introduction....3 Quality Control in the Laboratory...4 Infectious Disease (ID) QC....5 Ready-to-use Concept....6 NRL...7 QConnect...8 IAMQC in Collaboration with QConnect....

More information

Cardiac Assessment Controls A critical element of reliable cardiac testing

Cardiac Assessment Controls A critical element of reliable cardiac testing Cardiac Assessment Controls Cardiac Assessment Controls A critical element of reliable cardiac testing Choose the products best suited for your cardiac assessment needs Each year, 17.7 million people on

More information

GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE

GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE GLOBAL ANTIMICROBIAL RESISTANCE SURVEILLANCE Sonja Löfmark Public Health Agency of Sweden 6 th BARN Workshop May 12, 2016 Uppsala What is GLASS? A global programme for AMR surveillance The data it collects

More information

HIV-1 Seroconversion Panel

HIV-1 Seroconversion Panel A SERACARE PANEL PRODUCT Seroconversion INTENDED USE The Seroconversion is a group of serial bleeds from an individual plasma donor during seroconversion. This is intended for use by diagnostics manufacturers

More information

AccuVert HIV-1 Seroconversion Panel PRB974 ( )

AccuVert HIV-1 Seroconversion Panel PRB974 ( ) PACKAGE INSERT PRB974 (0600-0258) INTENDED USE PRB974 (0600-0258) is a group of serial bleeds from an individual plasma donor during seroconversion. This panel is intended for use by diagnostics manufacturers

More information

Laboratory Survey Results. Preventing disease, promoting and protecting health

Laboratory Survey Results. Preventing disease, promoting and protecting health Laboratory Survey Results Laboratory Survey 211 1 Bacteriology Laboratory Capacity in Twenty (2) CMC Percentage% Capacity 8 6 4 2 Campylobacter Cholera E. coli Leptospirosis N. meningitidis H. influenzae

More information

Vision and strategies to Increase Access to Innovative HIV Diagnostic Technologies. Willy Urassa. AMD STAKE HOLDERS MEETING 7-8 May 2013

Vision and strategies to Increase Access to Innovative HIV Diagnostic Technologies. Willy Urassa. AMD STAKE HOLDERS MEETING 7-8 May 2013 Vision and strategies to Increase Access to Innovative HIV Diagnostic Technologies Willy Urassa 1 Outline Definition Introduction Vision Broad strategies Progress so far Recent experience 2 Expansion of

More information

HIV-1 Seroconversion Panel PRB973

HIV-1 Seroconversion Panel PRB973 A SERACARE PANEL PRODUCT INTENDED USE The is a group of serial bleeds from an individual plasma donor during seroconversion. This panel is intended for use by diagnostics manufacturers and clinical laboratorians

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK West of Scotland Specialist Virology Centre New Lister Building Level 5 Glasgow Royal Infirmary 10-16 Alexandra Parade Glasgow G31 2ER Contact:

More information

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines Request for Letters of Intent International Development of H5N1 Influenza Vaccines The World Health Organization (WHO) intends to provide funding to developing (1) country vaccine manufacturers to develop

More information

AccuSet Anti-HIV-1 Mixed Titer Performance Panel

AccuSet Anti-HIV-1 Mixed Titer Performance Panel PACKAGE INSERT PRB205(M3) / (0800-0379) INTENDED USE The Performance Panel PRB205(M3) / (0800-0379) is intended for use by diagnostics manufacturers and clinical laboratorians to evaluate their HIV-1 test

More information

Third Party Controls for Your Dade Behring Systems

Third Party Controls for Your Dade Behring Systems Bio-Rad Laboratories Q U A L I T Y C O N T R O L Third Party Controls for Your Dade Behring Systems The Complete QC Solution from Bio-Rad Laboratories Bio-Rad has the control you need for your Dade Behring

More information

Expression of HIV-1 Markers During Progression of Infection E E E Days Since 1st Bleed

Expression of HIV-1 Markers During Progression of Infection E E E Days Since 1st Bleed Seroconversion OVERVIEW HIV-1 AccuVert TM Seroconversion PRB970 is a 4 member, 1.0 ml per vial panel of undiluted, naturally-occurring plasma samples. members represent serial bleeds collected from a single

More information

WHO Prequalification of In Vitro Diagnostics Programme

WHO Prequalification of In Vitro Diagnostics Programme WHO Prequalification of In Vitro Diagnostics Programme International HIV/Viral Hepatitis Co-Infection Satellite Meeting 19 July 2014, Melbourne Anita Sands Prequalification Diagnostics Team Department

More information

True Status A B. HTLV I Positive. Indeterminate. HTLV I/II Negative HV15 HV16 HV18 HV21 HV22 HV44 HV55. Selected Legend: Flagged: Unresolved

True Status A B. HTLV I Positive. Indeterminate. HTLV I/II Negative HV15 HV16 HV18 HV21 HV22 HV44 HV55. Selected Legend: Flagged: Unresolved National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 206Apr2 Panel

More information

HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 2016Oct28

HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 2016Oct28 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory HTLV Serology Quality Assessment Program Summary for Panel HTLVSER 2016Oct28

More information

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK National Institute for Biological Standards and Control (NIBSC) EC Certificate - Full Quality Assurance System Approval Certificate Annex IV (excluding sections 4 and 6) of Council Directive 98/79/EC on

More information

Standardization for Preclinical Evaluation of Influenza Vaccines in Animal Models - WHO activities

Standardization for Preclinical Evaluation of Influenza Vaccines in Animal Models - WHO activities Standardization for Preclinical Evaluation of Influenza Vaccines in Animal Models - WHO activities 2 nd WHO Integrated Meeting on development and clinical trials of Influenza vaccines that induce broadly

More information

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Murex HIV Ag/Ab Combination Number: PQDx

WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT. Product: Murex HIV Ag/Ab Combination Number: PQDx WHO Prequalification of In Vitro Diagnostics Programme PUBLIC REPORT Product: Murex HIV Ag/Ab Combination Number: PQDx 0144-043-00 Abstract Murex HIV Ag/Ab Combination with product codes 7G79-09 (GE41,

More information

OIE Reference Laboratory Reports Activities

OIE Reference Laboratory Reports Activities OIE Reference Laboratory Reports Activities Activities in 2014 This report has been submitted : 2015-01-16 15:04:37 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Equine

More information

AccuSet Anti-HIV-1 Mixed Titer Performance Panel

AccuSet Anti-HIV-1 Mixed Titer Performance Panel signal to cut-off (s/co) DATA SHEET OVERVIEW PRB205(M3) is a modified 16-member panel originating from Anti- HIV-1 Mixed Titer PRB205(M2). Panel members 3, 5, 6, 17, 21, 22, 23, 24, and 25 from the original

More information

NHS PREPAREDNESS FOR A MAJOR INCIDENT

NHS PREPAREDNESS FOR A MAJOR INCIDENT NHS PREPAREDNESS FOR A MAJOR INCIDENT In light of the recent tragic events in Paris, NHS England has asked that the Trust reviews the following, and that assurance is provided in the form of a Statement

More information

HIV-1 Seroconversion Panel PRB975

HIV-1 Seroconversion Panel PRB975 Seroconversion OVERVIEW is a five member HIV Seroconversion collected from a single donor over a 14 day period in 2002, prior to antibody seroconversion. -03 is a challenging sample for HIV RNA assays,

More information

2008 Public Status Report on the Implementation of the European Risk Management Strategy. Executive Summary

2008 Public Status Report on the Implementation of the European Risk Management Strategy. Executive Summary European Medicines Agency London, 17 March 2009 Doc. Ref. EMEA/43556/2009 2008 Status Report on the Implementation of the European Risk Management Strategy Executive Summary The European Risk Management

More information

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Royal Liverpool & Broadgreen University Hospitals NHS Trust Department of Virology Liverpool Clinical Laboratories Royal Liverpool and Broadgreen

More information

Update on WHO Prequalification of IVDs

Update on WHO Prequalification of IVDs Update on WHO Prequalification of IVDs Geneva, 11 March 2016 Mercedes Perez Gonzalez Anita Sands Prequalification Team - Diagnostics World Health Organization Outline Progress and Pipeline Ongoing concerns

More information

Bio-Rad Laboratories. Hemoglobin Testing. VARIANT II Hemoglobin Testing System For HbA 1c

Bio-Rad Laboratories. Hemoglobin Testing. VARIANT II Hemoglobin Testing System For HbA 1c Bio-Rad Laboratories Hemoglobin Testing VARIANT II Hemoglobin Testing System For HbA 1c Bio-Rad CDM System CDM 5.1 VII Instrument Patient Report V2_A1c_NU Patient Data Sample ID: AD Patient ID: Name: Physician:

More information

QA Processes. Philip DaCosta BSCP QA Lead, Yorkshire & the Humber September 2013

QA Processes. Philip DaCosta BSCP QA Lead, Yorkshire & the Humber September 2013 QA Processes Philip DaCosta BSCP QA Lead, Yorkshire & the Humber September 2013 Standards QA visits Dashboards BCSP standards Standards for Organisation Service delivery Reporting Data quality Audit and

More information

REPORT. Introduction. Satu Kurkela, Cohort 1 Centre for Infections of the Health Protection Agency in London, United Kingdom

REPORT. Introduction. Satu Kurkela, Cohort 1 Centre for Infections of the Health Protection Agency in London, United Kingdom REPORT, Cohort 1 Centre for Infections of the Health Protection Agency in London, United Kingdom Introduction Promoting and supporting capacity building of microbiological laboratory services in Member

More information

Guidance for obtaining faecal specimens from patients with diarrhoea (Background information)

Guidance for obtaining faecal specimens from patients with diarrhoea (Background information) Guidance for obtaining faecal specimens from patients with diarrhoea (Background information) Version 1.0 Date of Issue: January 2009 Review Date: January 2010 Page 1 of 11 Contents 1. Introduction...

More information

making a referral for breast imaging Standard Operating Procedure

making a referral for breast imaging Standard Operating Procedure Document Control Title Reporting Radiographer Author Directorate Surgery Date Version Issued 0.1 May 2016 Status Draft Author s job title Reporting Radiographer Department Breast Imaging Comment / Changes

More information

Royal College of Radiologists (RCR) Referral guidelines. Final Accreditation Report. Guidance producer: Guidance product: Date: 29 June 2010

Royal College of Radiologists (RCR) Referral guidelines. Final Accreditation Report. Guidance producer: Guidance product: Date: 29 June 2010 Guidance producer: Royal College of Radiologists (RCR) Guidance product: Referral guidelines Date: 29 June 2010 Final Accreditation Report Contents Introduction... 3 Accreditation recommendation... 3 Implementation...

More information

Rapid Review Laboratory Testing In Clinical Medicine Text With Internet Access Code For Student Co

Rapid Review Laboratory Testing In Clinical Medicine Text With Internet Access Code For Student Co Rapid Review Laboratory Testing In Clinical Medicine Text With Internet Access Code For Student Co We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks

More information

UKNEQAS Toxoplasma Serology. It is the fault of the kits or is it?

UKNEQAS Toxoplasma Serology. It is the fault of the kits or is it? UKNEQAS Toxoplasma Serology It is the fault of the kits or is it? Purpose of the Schemes The Toxoplasma subschemes consist of IgG and IgM and are designed to: Provide information allowing participants

More information

Table Of Content. European surveillance of travel associated legionnaires' disease... 2 Summary... 3 Coordinator, Leader contact and partners...

Table Of Content. European surveillance of travel associated legionnaires' disease... 2 Summary... 3 Coordinator, Leader contact and partners... Table Of Content European surveillance of travel associated legionnaires' disease... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Statens Serum Institute... 5 National Environmental Health

More information

Serology and International units

Serology and International units Serology and International units L. Grangeot-Keros, National Reference Laboratory for Rubella, Virology Department, A. Béclère Hospital, Clamart, France Detection of rubella-specific IgG antibody Assays

More information

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere HIV Combo WHO reference number: PQDx

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere HIV Combo WHO reference number: PQDx WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT Product: Alere HIV Combo WHO reference number: PQDx 0243-013-00 Alere HIV Combo with product codes 7D2842, 7D2843, 7D2843SET manufactured by Alere

More information

MEETING THE STANDARDS: FDA MANDATORY RAPID INFLUENZA DETECTION TEST (RIDTs) RECLASSIFICATION

MEETING THE STANDARDS: FDA MANDATORY RAPID INFLUENZA DETECTION TEST (RIDTs) RECLASSIFICATION MEETING THE STANDARDS: FDA MANDATORY RAPID INFLUENZA DETECTION TEST (RIDTs) RECLASSIFICATION NOVEMBER 6, 2017 SALLY A. HOJVAT M.Sc., Ph.D. Retired as Director of FDA Division of Microbiology Devices, CDRH

More information

HIV-1 Seroconversion Panel PRB964

HIV-1 Seroconversion Panel PRB964 A SERACARE PANEL PRODUCT Seroconversion INTENDED USE The is a group of serial bleeds from an individual plasma donor during seroconversion. This is intended for use by diagnostics manufacturers and clinical

More information

Primary Sample Manual Infectious Serology Issue No Effective Date: 20/09/17 Page 1 of 15 EUROFINS BIOMNIS

Primary Sample Manual Infectious Serology Issue No Effective Date: 20/09/17 Page 1 of 15 EUROFINS BIOMNIS Issue No. 2.02 Effective Date: 20/09/17 Page 1 of 15 Written / Revised By: Dr. Mike Louw, Medical Director Date: Reviewed By: Date: Dr. Sinead Kelly, Infectious Serology Consultant Authorised By: Jean-Sébastien

More information

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: SOP number: SOP category: Version number: 03 Version date: 19 December 2016 Effective date: 19 January 2017 Revision due date: 19 January 2020 NEWCASTLE CLINICAL TRIALS UNIT STANDARD

More information

The Inclusion of Seasonal Influenza Viruses and Genetic Sequence Data (GSD) in the Context of the Pandemic Influenza Preparedness (PIP) Framework

The Inclusion of Seasonal Influenza Viruses and Genetic Sequence Data (GSD) in the Context of the Pandemic Influenza Preparedness (PIP) Framework The Inclusion of Seasonal Influenza Viruses and Genetic Sequence Data (GSD) in the Context of the Pandemic Influenza Preparedness (PIP) Framework A position paper from the Directors of the GISRS WHO Collaborating

More information

Confirmatory Testing Algorithm. Routine Donor Testing Algorithm

Confirmatory Testing Algorithm. Routine Donor Testing Algorithm Confirmatory Testing Algorithm Blood Confirmatory ABO/Rh Beckman Coulter PK-ABO/Rh Immucor NEO ABO/Rh Immucor NEO ABO/Rh Immucor Manual ABO/Rh Typing Immucor Manual ABO/Rh Typing Discrepancy Resolution

More information

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

EURO POLIO PAGE Data as of 04 October 2005 (Week 38) World Health Organization Regional Office for Europe EURO POLIO PAGE Data as of 04 October 2005 (Week 38) Vaccine-preventable Diseases and Immunization programme, Division of Technical Support website:

More information

The New Regulations - Special IVD Issues

The New Regulations - Special IVD Issues The New Regulations - Special IVD Issues Dirk Stynen, Ph. D. President - Principal Consultant Qarad Geel, Belgium RMD Brussels October 2018 The IVD Regulation 2017/746 October 29, 2018 www.qarad.com 2

More information

With the aim of continuous improvement of our products, Biokit increases the shelf life of bioelisa HIV 1+2 Ag/Ab from 10 to 12 months.

With the aim of continuous improvement of our products, Biokit increases the shelf life of bioelisa HIV 1+2 Ag/Ab from 10 to 12 months. 1 NEWS BK NEWS # 377 /MKT DATE : 18-01-2016 TITLE : SHELF-LIFE EXTENSION OF bioelisa HIV 1+2 Ag/Ab With the aim of continuous improvement of our products, Biokit increases the shelf life of bioelisa HIV

More information

Prequalification of In Vitro Diagnostics. WHO PROTOCOL for laboratory evaluation of Combined HIV/Syphilis serology assays. PQDx_150. Version: 4.

Prequalification of In Vitro Diagnostics. WHO PROTOCOL for laboratory evaluation of Combined HIV/Syphilis serology assays. PQDx_150. Version: 4. SOP_ WHO PROTOCOL FOR THE LABORATORY EVALUATION OF COMBINED HIV/SYPHILIS SEROLOGY ASSAYS Prequalification-In vitro Diagnostics Assessment Prequalification of In Vitro Diagnostics WHO PROTOCOL for laboratory

More information

Guidance on the use of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories 2011

Guidance on the use of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories 2011 Guidance on the use of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories 2011 Molecular testing for gonorrhoea working group (see Appendix) Prepared by Kirstine Eastick March 2012-1

More information

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014 Good Laboratory Practice EU-Serbia screening meeting Brussels, 19 June 2014 Table of contents 1. Background information on the principles of GLP 2. EU legal basis for GLP 3. Role of Member States 4. Role

More information

DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations

DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations Dear User, ISSUE: M008 DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations In order to comply with national quality guidance and as part of our

More information

APHL Next Generation Sequencing (NGS) Survey

APHL Next Generation Sequencing (NGS) Survey Next Generation Sequencing 1. How long has your lab had a sequencer? [If lab does not have a sequencer go to 1a1 through 1a3 and then end survey] [If lab does have a sequencer continue to 1a and the rest

More information

Core Standard 24. Cass Sandmann Emergency Planning Officer. Pat Fields Executive Director for Pandemic Flu Planning

Core Standard 24. Cass Sandmann Emergency Planning Officer. Pat Fields Executive Director for Pandemic Flu Planning Trust Board Meeting Agenda Item 7 Date: 30 September 2009 Title of Report Recommendations (please outline the purpose of the report and the key issues for consideration/decision) Progress with Pandemic

More information

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen Screening donors and donations for transfusion transmissible infectious agents Alan Kitchen Aim Not to teach you microbiology To provide and awareness of the big picture To provide an understanding of

More information

Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience

Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience Current strategies, initiatives and challenges to mitigate biorisk: Indonesia s experience Head of Delegation HERAWATI SUDOYO MD, PHD Eijkman Institute for Molecular Biology Ministry for Research and Technology

More information

Immunohematology. IH-QC Modular System. Select. Combine. Control.

Immunohematology. IH-QC Modular System. Select. Combine. Control. Immunohematology IH-QC Modular System Select. Combine. Control. IH-QC Modular System Select. Combine. Control. Transfusion guidelines recommend regular checking of test materials, test methods, local working

More information

Global EHS Resource Center

Global EHS Resource Center Global EHS Resource Center Understand environmental and workplace safety requirements that affect your global operations. 800.372.1033 bna.com/gelw Global EHS Resource Center This comprehensive research

More information

SUMMARY OF THE DISCUSSION AND RECOMMENDATIONS OF THE SARS LABORATORY WORKSHOP, 22 OCTOBER 2003

SUMMARY OF THE DISCUSSION AND RECOMMENDATIONS OF THE SARS LABORATORY WORKSHOP, 22 OCTOBER 2003 SUMMARY OF THE DISCUSSION AND RECOMMENDATIONS OF THE SARS LABORATORY WORKSHOP, 22 OCTOBER 2003 An informal SARS Laboratory Workshop was held at WHO, Geneva, on Wednesday, 22 October 2003, to discuss aspects

More information

AccuSet HIV-1/2 Performance Panel

AccuSet HIV-1/2 Performance Panel OVERVIEW AccuSet HIV-1/2 (0800-0380) is a 13-member validation panel of undiluted, naturally occurring plasma samples (1 vial per member, 1.0 ml per vial). Panel members represent bleeds from multiple

More information

Diagnostic Tests for HIV

Diagnostic Tests for HIV Mountain West AIDS Education and Training Center Diagnostic Tests for HIV David Spach, MD Principal Investigator, Mountain West AETC Professor of Medicine, University of Washington Last Updated: June 22,

More information

Draft Report WHO evaluation of HIV 1/2 STAT-PAK (Chembio Diagnostic Systems Inc)

Draft Report WHO evaluation of HIV 1/2 STAT-PAK (Chembio Diagnostic Systems Inc) Date: 6 January 2012 Draft Report WHO evaluation of HIV 1/2 STAT-PAK (Chembio Diagnostic Systems Inc) WHO Collaborating Centre for HIV/AIDS Diagnostic and Laboratory Support Department of Clinical Sciences

More information

An Introduction to Access to Diagnostics. 14:00-14:45 BST 17 June

An Introduction to Access to Diagnostics. 14:00-14:45 BST 17 June An Introduction to Access to Diagnostics 14:00-14:45 BST 17 June Chair: Dr Greg Martin, Specialist Registrar, Public Health Medicine and Editor-in- Chief of Globalization and Health @drgregmartin Speakers:

More information

EU REFERENCE LABORATORIES FOR AVIAN INFLUENZA AND NEWCASTLE DISEASE

EU REFERENCE LABORATORIES FOR AVIAN INFLUENZA AND NEWCASTLE DISEASE EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL G2- Animal Health 04 Veterinary Control programmes SANCO/7048/204 Draft Working document EU REFERENCE LABORATORIES FOR AVIAN INFLUENZA AND NEWCASTLE

More information

1 st and 2 nd Generation EIA

1 st and 2 nd Generation EIA HIV Diagnostic Tests Bernard M. Branson, M.D. Associate D irector for Laboratory D iagnostics Division of HIV/AIDS Prevention Centers for D isease Control & Prevention The views expressed in this presentation

More information

Feedback from the Member States questionnaire

Feedback from the Member States questionnaire Annex 6 Feedback from the Member States questionnaire Reinhilde A.R. Schoonjans Special meeting of the EFSA Advisory Forum on GMO risk assessment in Europe 13 November 2007, Brussels Topics 1. Highlights

More information

Sets out clearly the DoH s expectations of the NHS and the roles and responsibilities of each part of the system over the coming months.

Sets out clearly the DoH s expectations of the NHS and the roles and responsibilities of each part of the system over the coming months. NORTH EAST AMBULANCE SERVICE NHS TRUST UPDATE AND RESILIENCE ACTIONS FOR NHS BOARDS REPORT BY : Director of Ambulance Operations INTRODUCTION As Board members are aware, the World Health Organisation (WHO)

More information

NIOSH Respiratory Protective Device Priorities - Opportunities for International Collaboration

NIOSH Respiratory Protective Device Priorities - Opportunities for International Collaboration NIOSH Respiratory Protective Device Priorities - Opportunities for International Collaboration Maryann D Alessandro, Ph.D. Director, NPPTL PPT Program Manager ISRP Keynote Address September 22, 2014 1

More information